Whitepaper
27 Apr 2021

Meeting Quality Demands Through Integrated Products and Services

PDF 1.8 MB

Lars Keinicke Hansen, Chiara Mussoi, and Odra Pinato, all of Stevanato Group, describe how the streamlining of processes and harmonisation of products and services can better serve pharmaceutical companies. A case study highlights how a unique combination of expertise in automation and glass primary packaging benefited pharma giant Merck Serono in a recent project.

Content provided by our supplier

Stevanato Group SPA

  • IT
  • 2015
    On CPhI since

Other Content from Stevanato Group SPA

  • News Growth opportunities abound for auto-injectors amid patient-centric healthcare transition, experts tell CPhI webinar

    Tremendous growth opportunities exist for auto-injectors as their value is increasingly being recognised across several therapy areas, experts have told a recent CPhI webinar, sponsored by Stevanato Group.
  • Brochure SG Nexa 3x Cartridges: Three times the mechanical resistance of a standard glass cartridge

    Stevanato Group has launched SG Nexa 3x Cartridges, a full range of products that offer up to 3 times the mechanical resistance when compared to a standard glass container.
    Thanks to an external anti-friction and anti-scratches silicone coating, SG Nexa 3x better withstands the stresses of fill/finish processes too.
  • News WEBINAR: Early stage considerations for the manufacture and delivery of vaccines: Watch Now!

    Watch this recent webinar exploring the challenges of distributing COVID-19 vaccines to a global population and the role the packaging sector is playing to ensure safe and speedy distribution of shots
  • News Streamlining biologics and biosimilars drug development process through a single source

    The increasing number of complex and sensitive biologics and the administration shift from hospitals to patients' homes are two of today’s main biopharmaceutical industry challenges. Complex drugs and self-administration require an appropriate primary packaging selection from the beginning of the bio drug development process. In this article, you will learn how Stevanato Group can support biopharma companies in the container closure system choice leveraging its 70-year expertise in glass primary packaging, up to the integration into drug delivery systems, backed up by solid characterization analysis.

    Stevanato Group

  • Video Modular and flexible Assembly Equipment

    Assembly Equipment combining transport platforms and process modules: an offer of manual, semi-automatic or fully automatic assembly lines customized to your device program.
  • News Stevanato Group signs agreement with Gerresheimer to provide integrated twist-off closure system solution, ITC, for Gx RTF syringes

    SG ITC (Integrated Tip Cap), the twist-off closure of Stevanato Group, is an established and especially user-friendly system solution for Luer Lock syringes, which will now be included in Gerresheimer program.
  • Video Pen Injector Assembly Line

    A flexible mid-high speed pen injector line assembling different formats and integrating extensive in-process controls.
  • News Stevanato Group and Bexson Biomedical announce collaboration to develop a customized wearable ketamine delivery device

    Patients suffering from chronic and acute pain disorders will benefit from a convenient, discreet, and easy-to-use device delivering a novel alternative to opioid-based pain management.
  • Video Trends in Auto-Injectors

    This recent webinar sponsored by Stevanato Group focuses on early considerations for emergency use auto-injector development and manufacturing.

    Presenting a case study on Stevanato’s Maverick, Adam Stops, Drug Delivery Systems Product Manager at Stevanato Group explained that the emergency use auto-injector is the result of a successful partnership with Duoject Medical Systems.

    “We have partnered with Duoject to provide a market-leading device for our customers in the emergency use space. Along with Novocol, Duoject’s parent company, if requested, we can provide end-to-end services: the device, device manufacturing, fill/finish, and final device assembly. This is truly an end-to-end solution,” he said.

    Watch the webinar to hear more from Adam and other experts from Duoject Medical Systems and IQVIA.
  • Video Early stage considerations for the manufacture and delivery of vaccines webinar

    The COVID-19 pandemic has placed a spotlight on the readiness and requirements of pharma packaging companies to support the distribution and delivery of a potential vaccine and selecting the most suitable primary packaging options for drug products is one of the most crucial considerations in the drug development process, according to industry experts speaking in this CPhI China Virtual Expo Connect Webinar, sponsored by Stevanato Group. Daniel Martinez, Product Manager, Stevanato Group pointed out that speed to market is a primary consideration for vaccine developers, particularly in the current pandemic environment, and keeping the same type of container is essential to reaching this target. “The advantage of using a vial is that it is a pretty versatile container – it’s good for liquids, it’s good for lyophilized products, powders and cryogenic,” he told the audience, noting that some of the COVID-19 vaccines being developed need to be stored at -70 degrees. Watch the webinar to hear more from Daniel and experts from NRL Enterprise Solutions & IQVIA.
  • Video Maverick: Innovative cartridge-based auto-injector for emergency use

    Stevanato Group and Duoject Medical Systems are developing a reliable and user-friendly auto-injector for emergency use, suitable for an effective and fast intramuscular injection.
    The device features an intuitive activation, while the needle is never exposed and automatically retracted after injection.